OUR LEADERSHIP
Our team of experienced innovators represents a unique constitution of talent across the life science and technology industries.
We pride ourselves in building a company where people with executive experience in pharma
and clinical research are collaborating with best-in-class programmers and interaction designers.
Lollo Eriksson
Chief Executive Officer
Lollo has a 30 year successful career with Merck & Co., Inc behind him, having joined this company after completing training as a clinical pharmacologist. He has held various leading positions within Merck Research Laboratories (MRL), including clinical pharmacology, clinical research development and clinical research operations across geographies. In addition to this, he has 8 years of executive leadership experience from the global CRO business focusing on study feasibility, study-start-up, patient recruitment and health care alliances and acquisitions. His main areas of focus include patient engagement and novel cost-effective recruitment strategies.
Annette Colin Lövgren
Chief Financial Officer /
Deputy Chief Executive Officer
Annette has more than 25 years of experience, whereof 13 years in Life Science, of executive positions such as CEO, CFO, COO, Tax Manager and as a board member. Her experience span several M&A and IPO transactions with a total deal value of $3 billion, representing Venture Capital, Private Equity as well as stock listed companies. Recent assignments include Annexin Pharmaceuticals AB, Observe Medical International, Stille AB, Lindab International AB, Perbio Science AB and E&Y. Annette holds a University degree in Business Administration, Marketing, Organisation learning and Law from Lund University, Sweden.
Robert Molander
Chief Marketing Officer
Robert has a 25-year record of driving breakthrough growth and new launches. He has held leadership positions including: Global Head of New Growth Opportunities for Novartis Consumer Healthcare; Head of US Marketing for Shionogi Pharmaceuticals; Marketing and Sales leadership roles at Novartis Pharmaceuticals and Pfizer Consumer Health; preceded by a Consumer Package Goods marketing career with Nestlé Purina Pet Care. He has served on the Executive Council for Harvard Medical School’s Division of Sleep Medicine, and holds an MBA from Washington University and BA’s from Miami University in Economics and International Studies.
Max Westling
Chief Operating Officer
Max is a seasoned business strategist with extensive experience of advising the pharmaceutical and healthcare industries on new opportunities for growth as well as how to drive operational efficiencies across the value chain. During his tenure with Accenture Strategy, Max partnered with clients to influence priority c-suite issues at the intersection of business and technology, with a special focus on operating model architecture in clinical research. As COO of Trialbee, Max provides the leadership, management and vision necessary to ensure that Trialbee has the proper operational controls and systems in place to effectively grow the organization. Max holds an MSc in Industrial Engineering & Management from Lund University, Sweden.
Jeff Rogers
Chief Commercial Officer
Jeff brings 25 years of cross-functional sales and operational leadership to Trialbee where he is responsible for developing and guiding Trialbee’s Commercial team in support of Pharmaceutical, Biotech and CRO clients around the Globe. Since 2007, Jeff has been instrumental in driving the commercial success for several start-up and emerging growth organizations where his commitment, passion and vision have led to the introduction of new and innovative technology-based solutions that allow companies conducting clinical trials to optimize their clinical development process, streamline activities and improve financial results. Jeff holds a B.S. degree in Business Management from Providence College in Providence, RI.